United States: There’s Clear Evidence FDA Rejected Fosamax Femur Fracture Warning
Mealey's (October 3, 2018, 12:37 PM EDT) -- WASHINGTON, D.C. — The United States on Sept. 20 sided with Merck Sharp & Dohme that there is clear evidence that the Food and Drug Administration rejected a stronger warning about...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login